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Background: Valsalva retinopathy is a known medical condition which happens after valsalva maneuver. The aim
of this study was to report a case of young asian pregnant female presented with acute visual loss due to the
valsalva retinopathy, followed by spontaneous visual recovery.
Case presentation: A case of 23 years-old pregnant Asian female with 31 weeks of gestation presented with
history of a sudden decrease in vision in her left eye from seven hours prior to the visit. Based on clinical findings,
laboratory test and imaging studies, the diagnosis of Valsalva retinopathy was confirmed. Subsequently, her normal
vision was returned during three months with no intervention.
Conclusion: Pregnancy is a risk factor for Valsalva retinopathy. Valsalva retinopathy generally has a good prognosis.
Vision usually returns to normal over a short period of time and requires only observation.
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Valsalva retinopathy was first described in 1972 by
Thomas Duane as “a particular form of retinopathy, pre-
retinal and hemorrhagic in nature, secondary to a sud-
den increase in intrathoracic pressure.” Immediately
after a Valsalva maneuver, there is a sudden increase in
intraocular venous pressure causes retinal capillaries to
rupture spontaneously [1].
The patient often gives a history of a recent strenuous
physical activity, which may increase the intra-thoracic
pressure. Pregnancy is known to be a risk factor for Val-
salva retinopathy [2]. We, therefore, report valsalva ret-
inopathy in a young healthy pregnant woman with
spontaneous resolution with no sequelae.Case presentation
A 23 years old pregnant Asian female with 31 weeks of
gestation presented with a history of a sudden decrease
in vision in her left eye from seven hours prior to the
initial visit. Her clinical problems were initiated after se-
vere retching and vomiting due to the ingestion of fer-
rous sulfate tablets. Her previous medical history was
unremarkable. Ophthalmic examination showed best
corrected visual acuity of 20/20 in the right eye and* Correspondence: sharifim@mums.ac.ir
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sponse, eye movement and anterior segment evaluations
were normal. Fundus examination revealed large (10–15
disc diameters) pre-retinal hemorrhage located in the
macula (Figure 1). Blood pressure (BP), complete blood
count (CBC), coagulation profiles and fasting blood glu-
cose (FBS) were within the normal ranges. Based on the
clinical findings and laboratory studies, the diagnosis of
Valsalva retinopathy was confirmed. Conservative man-
agement including rest position, observation of vital
signs and avoidance of strenuous activities were recom-
mended. Finally, she underwent normal vaginal delivery
(NVD) without any complications. The vision of the pa-
tient returned to 20/20 and hemorrhage was resorbed
completely during three months after the delivery
(Figure 2).Discussion
Valsalva retinopathy usually occurs in healthy adults and
has been reported following coughing, weight lifting,
vomiting, jumping, end-stage of labor, episodes of con-
stipation, vomiting and lifting in pregnant women [1,3].
Pregnancy exerts multiple hormonal, metabolic,
hematological and immunological alterations in the
mother that may represent risk factors for Valsalva
retinopathy.
Elevation of intra-abdominal pressure during preg-
nancy, with a further increase during labor, leads to ais is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Figure 1 Large pre retinal macular hemorrhage in
valsalva retinopathy.
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may increase the potential for retinal hemorrhages fol-
lowing a Valsalva maneuver [2].
Moreover, hematological alterations during the preg-
nancy such as thrombocytopenia add to the risk of Val-
salva retinopathy in pregnancy [2]. In such clinical
scenarios, it is important to rule out all systemic dis-
eases that may result in retinal hemorrhages such as
diabetes, hypertension, sickle cell disease, anemia, co-
agulopathy, blood dyscrasias and previous ocular vein
occlusions [2].
The prognosis for patients diagnosed with merely Val-
salva retinopathy is generally good and the condition re-
quires only close observations. Vision usually returns to
normal over a short period of time, from weeks toFigure 2 Complete absorption of macular hemorrhage after
three months in valsava retinopathy.months [1]. Some patients may have a poor visual out-
come, which has been attributed to retinal pigmentary
changes in the macula [4].
An yttrium aluminum garnet (YAG) laser has been
employed in selective cases to disperse the pre-retinal
hemorrhages and speed up the resolution [5].
Whether vaginal delivery poses a risk of recurrence or
exacerbation of the hemorrhage is not fully understood
[3]. A review of the literature showed no recurrence of
retinopathy following spontaneous vaginal delivery
[3,4]. The case of the present study had normal vaginal
delivery which was recommended by her obstetrician.
Epidural anesthesia accompanied with adequate sed-
ation was applied for the decrease of pain and strenuous
activity during labor.
Conclusion
Valsalva retinopathy is a self-limited condition. Preg-
nancy is one of the known risk factor for this condition.
Most patients are managed conservatively with good
outcome.
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